Aspirin sensitive asthma and arachidonic acid transformation.
Inhibition by nonsteroidal antiinflammatory drugs of cyclooxygenase appears to be the basic mechanism operating in aspirin-sensitive asthma. Evidence in favor of this theory is presented. We also discuss biochemical consequences of blockade of cyclooxygenase for clinical symptomatology, prevention and treatment of aspirin-sensitive asthma.